Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Tau, Bayer, Concentra Biosciences, Deephealth, Eli Lilly, Genincode, Koelis, Masimo, Nico, Pathpresenter, Personalaize, Radnet, Renovaro, Renovarocube, Singular Genomics Systems, Stryker, T2 Biosystems, Tandem Diabetes Care, Trinity Biotech, World Tumor Registry.
Avicenna.ai SAS received U.S. FDA clearance for its Cina-Cspine algorithm, which uses machine learning technology to detect and triage cervical spine fractures from computed tomography images. The tool automatically flags imaging findings that are compatible with acute cervical spine fractures, which can cause serious neurological damage or paralysis.
The U.S. CMS believes it has a quandary on its hands with regard to transitional pass-through payment for renal denervation devices, but the Medical Device Manufacturers Association urged the agency to provide separate payment mechanisms for these devices as seen in the inpatient final rule.
As med-tech startups look to raise capital without diluting the valuation of their company, many may look to sell distribution rights in certain geographies to interested companies.
Australia is the skin cancer capital of the world, but with a shortage of dermatologists, patients often wait too long to get skin checks that could end up costing them their lives.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avicenna, GE Healthcare, Sonio.
RSS
